Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-312026-03-31false2025-04-0122truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10626478 2025-04-01 2026-03-31 10626478 2024-04-01 2025-03-31 10626478 2026-03-31 10626478 2025-03-31 10626478 c:Director1 2025-04-01 2026-03-31 10626478 d:MotorVehicles 2025-04-01 2026-03-31 10626478 d:MotorVehicles 2026-03-31 10626478 d:MotorVehicles 2025-03-31 10626478 d:MotorVehicles d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 10626478 d:FurnitureFittings 2025-04-01 2026-03-31 10626478 d:OfficeEquipment 2025-04-01 2026-03-31 10626478 d:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 10626478 d:OtherPropertyPlantEquipment 2026-03-31 10626478 d:OtherPropertyPlantEquipment 2025-03-31 10626478 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 10626478 d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 10626478 d:CurrentFinancialInstruments 2026-03-31 10626478 d:CurrentFinancialInstruments 2025-03-31 10626478 d:CurrentFinancialInstruments d:WithinOneYear 2026-03-31 10626478 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 10626478 d:ShareCapital 2026-03-31 10626478 d:ShareCapital 2025-03-31 10626478 d:RetainedEarningsAccumulatedLosses 2026-03-31 10626478 d:RetainedEarningsAccumulatedLosses 2025-03-31 10626478 c:OrdinaryShareClass1 2025-04-01 2026-03-31 10626478 c:OrdinaryShareClass1 2026-03-31 10626478 c:OrdinaryShareClass1 2025-03-31 10626478 c:OrdinaryShareClass2 2025-04-01 2026-03-31 10626478 c:OrdinaryShareClass2 2026-03-31 10626478 c:OrdinaryShareClass2 2025-03-31 10626478 c:OrdinaryShareClass3 2025-04-01 2026-03-31 10626478 c:OrdinaryShareClass3 2026-03-31 10626478 c:OrdinaryShareClass3 2025-03-31 10626478 c:FRS102 2025-04-01 2026-03-31 10626478 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 10626478 c:FullAccounts 2025-04-01 2026-03-31 10626478 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 10626478 2 2025-04-01 2026-03-31 10626478 6 2025-04-01 2026-03-31 10626478 15 2025-04-01 2026-03-31 10626478 16 2025-04-01 2026-03-31 10626478 17 2025-04-01 2026-03-31 10626478 19 2025-04-01 2026-03-31 10626478 20 2025-04-01 2026-03-31 10626478 d:AcceleratedTaxDepreciationDeferredTax 2026-03-31 10626478 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 10626478 e:PoundSterling 2025-04-01 2026-03-31 10626478 32 2025-04-01 2026-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 10626478









THOMPSON ORTHOPAEDICS LIMITED

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

YEAR ENDED 31 MARCH 2026

 
THOMPSON ORTHOPAEDICS LIMITED
REGISTERED NUMBER: 10626478

BALANCE SHEET
AS AT 31 MARCH 2026

2026
2025
Note
£
£

Fixed assets
  

Tangible assets
 4 
127,918
201,644

Investments
 5 
249,885
-

  
377,803
201,644

Current assets
  

Debtors: amounts falling due within one year
 6 
395,585
892,210

Cash at bank and in hand
  
1,139,310
1,284,530

  
1,534,895
2,176,740

Creditors: amounts falling due within one year
 7 
(857,829)
(421,154)

Net current assets
  
 
 
677,066
 
 
1,755,586

Total assets less current liabilities
  
1,054,869
1,957,230

Provisions for liabilities
  

Deferred tax
 8 
(31,980)
(50,411)

  
 
 
(31,980)
 
 
(50,411)

Net assets
  
1,022,889
1,906,819


Capital and reserves
  

Called up share capital 
 9 
100
100

Profit and loss account
  
1,022,789
1,906,719

  
1,022,889
1,906,819


Page 1

 
THOMPSON ORTHOPAEDICS LIMITED
REGISTERED NUMBER: 10626478

BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2026

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 October 2026.




Dr S M Thompson
Director

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.


General information

Thompson Orthopaedics Limited is a private Company limited by shares incorporated in England within the United Kingdom. The address of the registered office is Causeway House, 1 Dane Street, Bishop's Stortford, Hertfordshire, CM23 3BT. This Company is not part of a group.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
∙the amount of turnover can be measured reliably;
∙it is probable that the Company will receive the consideration due under the contract;
∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and
∙the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
straight-line
Fixtures and fittings
-
25%
straight-line
Office equipment
-
25%
straight-line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Valuation of investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Page 4

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.11

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit or loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Page 5

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)


2.11
Financial instruments (continued)

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

The Company classifies financial liabilities from its supplier finance arrangements as trade creditors as the arrangements have not substantively changed the payment dates and other contractual terms compared to the underlying trade creditors.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flows expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


 

Page 6

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)


2.11
Financial instruments (continued)

Offsetting

Financial assets and liabilities are offset and the net amount presented in the statement of financial position only when the Company has a legally enforceable right to set off the amounts and intends either to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 2).


4.


Tangible fixed assets


Motor vehicles
Other fixed assets
Total

£
£
£



Cost


At 1 April 2025
253,720
97,691
351,411


Additions
-
16,982
16,982


Disposals
-
(42,887)
(42,887)



At 31 March 2026

253,720
71,786
325,506



Depreciation


At 1 April 2025
103,935
45,832
149,767


Charge for the year on owned assets
63,429
16,441
79,870


Disposals
-
(32,049)
(32,049)



At 31 March 2026

167,364
30,224
197,588



Net book value



At 31 March 2026
86,356
41,562
127,918



At 31 March 2025
149,785
51,859
201,644

Page 7

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

5.


Fixed asset investments





Other fixed asset investments

£



Cost or valuation


Additions
249,885



At 31 March 2026
249,885




Page 8

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

6.


Debtors

2026
2025
£
£


Trade debtors
10,897
17,505

Other debtors
367,948
873,781

Prepayments and accrued income
16,740
924

395,585
892,210



7.


Creditors: Amounts falling due within one year

2026
2025
£
£

Trade creditors
-
1,378

Corporation tax
277,549
393,617

Other creditors
572,955
16,222

Accruals and deferred income
7,325
9,937

857,829
421,154



8.


Deferred taxation




2026


£






At beginning of year
50,411


Charged to profit or loss
(18,431)



At end of year
31,980

The provision for deferred taxation is made up as follows:

2026
2025
£
£


Accelerated capital allowances
31,980
50,411

31,980
50,411

Page 9

 
THOMPSON ORTHOPAEDICS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

9.


Share capital

2026
2025
£
£
Allotted, called up and fully paid



51 (2025 - 51) Ordinary shares of £1 each
51
51
25 (2025 - 25) Ordinary A shares of £1 each
25
25
24 (2025 - 24) Ordinary B shares of £1 each
24
24

100

100



10.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held
separately from those of the Company in an independently administered fund. The pension cost charge
represents contributions payable by the Company to the fund and amounted to £120,000 (2025 - £120,000).

Contributions totalling £Nil (2025 - £Nil) were payable to the fund at the balance sheet date and are
included in creditors. 


11.


Transactions with directors

At 1 April 2025, the director owed the Company £584,102. During the year they paid expenses on the Company's behalf of £Nil and a dividend of £1,355,000 was declared and credited to the director's loan account. They also withdrew amounts totalling £100,819 and the Company paid expenses on their behalf of £105,785. At 31 March 2026, £554,711 was owed to the Director.

Interest of £9,583 (2025: £12,853) was charged on the loan and S455 tax has been provided in respect of historic overdrawn balances. As the director's loan account is now considered repaid, the related S455 tax is fully recoverable.


Page 10